Minimally invasive delivery of a hydrogel-based exosome patch to prevent heart failure
Coronary heart disease (CHD) has been the number one killer in the United States for decades and causes millions of deaths each year. Clinical treatment of heart ischemic injury relieves symptoms in the acute stage of CHD; however, patients with an infarcted heart muscle can develop heart failure (HF) due to chronic maladaptive remodeling. Regenerative therapy has been studied as a potential treatment option for myocardial infarction (MI) and HF. Cardiac patches have been designed and tested to increase therapeutic retention and integration in this field.
Source: Journal of Molecular and Cellular Cardiology - Category: Cytology Authors: George Cheng, Dashuai Zhu, Ke Huang, Thomas G. Caranasos Source Type: research
More News: Cardiology | Coronary Heart Disease | Cytology | Heart | Heart Attack | Heart Disease | Heart Failure | USA Health